WHAT IT IS TRYING TO CHANGE
What the project is doing
TRIAD rapamycin trial in dogs is being developed as part of the wider effort to prevent, delay or repair age-related decline.
What this could do for you
If the effect in people is large enough, this could become a medicine used to slow one or more processes that drive age-related decline.
What has to happen next
The next checkpoint is a defined experiment, development partner or route into human testing.
What could stop it
The idea may never become a practical treatment, even when the biological reasoning is interesting.